Remegen Site #17 — Augusta, Georgia

Remegen Site #17 is a clinical research site located in Augusta, Georgia, United States 30909.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Remegen Site #17 has participated in 1 clinical trials.

Therapeutic areas: IgA Nephropathy.

Sponsors: RemeGen Co., Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Augusta

Browse all research sites in Georgia · View every site in Augusta

• Georgia Regents University MedCollege of GA Cancer Ctr 2
• Georgia Regents University Cancer Center
• Augusta University Health Pharmacy
• University Cardiology Associates
• Joseph M. Still Burn Center and Wound Clinic at Doctors Hospital
• Board of Regents of the University System of Georgia
• Walton Rehabilitation Hospital
• Augusta VA Medical Center
• Georgian Cancer Center at Augusta University
• Doctors Hospital of Augusta
• Georgia Regents University Augusta
• Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Remegen Site #17?

Remegen Site #17 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Remegen Site #17 conducted?

Remegen Site #17 has 1 clinical trials on record. Their work covers IgA Nephropathy.

Is Remegen Site #17 accredited by Crixeo Clinical Trials?

Remegen Site #17 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Remegen Site #17?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.